Article
VLP-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and…
medRxiv · 2023 · Ana Barajas
Key facts
| Title | VLP-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice |
|---|---|
| First author | Ana Barajas |
| Journal | medRxiv |
| Published | Sep 12, 2023 |
| DOI | 10.1101/2023.09.07.556652 |
| Devices mentioned | K073490 |
| Product codes mentioned | CEK, CFN, KSZ, MVU, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1